Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jack

Showing results (291-300 of 594) with videos related to

Pageof 60
Sort By:
JNCI Cancer Spectrum|June 21, 2019
Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung CancerJennifer S Davis, Erin Prophet, Ho-Lan Peng, et al.
Molecular Cancer Therapeutics|July 11, 2007
Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasionAnne S Tsao, Dandan He, Babita Saigal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 24, 2002
Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesionsVassiliki A Papadimitrakopoulou, Diane D Liu, Li Mao, et al.
Journal of the National Cancer Institute|January 17, 2003
Retinoic acid receptor beta and telomerase catalytic subunit expression in bronchial epithelium of heavy smokersJean-Charles Soria, Xiaochun Xu, Diane D Liu, et al.
Carcinogenesis|September 8, 2010
MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancerXiaofan Zhang, Hushan Yang, J Jack Lee, et al.
Journal of Adolescent and Young Adult Oncology|May 23, 2017
Racial Differences in 20-Year Cardiovascular Mortality Risk Among Childhood and Young Adult Cancer SurvivorsAmy M Berkman, Abenaa M Brewster, Lee W Jones, et al.
Plos One|August 11, 2011
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancersFilip Janku, J Jack Lee, Apostolia M Tsimberidou, et al.
Oral Oncology|January 25, 2018
HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancersSara I Pai, J Jack Lee, Thomas E Carey, et al.
Journal of Biomedical Optics|January 5, 2011
Comparison of multispectral wide-field optical imaging modalities to maximize image contrast for objective discrimination of oral neoplasiaDarren Roblyer, Cristina Kurachi, Vanda Stepanek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2017
Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial ImprovementChad Tang, Steven I Sherman, Mellanie Price, et al.
Pageof 60

Showing results (291-300 of 594) with videos related to

Sort By:
Pageof 60
JNCI Cancer Spectrum|June 21, 2019
Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung CancerJennifer S Davis, Erin Prophet, Ho-Lan Peng, et al.
Molecular Cancer Therapeutics|July 11, 2007
Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasionAnne S Tsao, Dandan He, Babita Saigal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 24, 2002
Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesionsVassiliki A Papadimitrakopoulou, Diane D Liu, Li Mao, et al.
Journal of the National Cancer Institute|January 17, 2003
Retinoic acid receptor beta and telomerase catalytic subunit expression in bronchial epithelium of heavy smokersJean-Charles Soria, Xiaochun Xu, Diane D Liu, et al.
Carcinogenesis|September 8, 2010
MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancerXiaofan Zhang, Hushan Yang, J Jack Lee, et al.
Journal of Adolescent and Young Adult Oncology|May 23, 2017
Racial Differences in 20-Year Cardiovascular Mortality Risk Among Childhood and Young Adult Cancer SurvivorsAmy M Berkman, Abenaa M Brewster, Lee W Jones, et al.
Plos One|August 11, 2011
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancersFilip Janku, J Jack Lee, Apostolia M Tsimberidou, et al.
Oral Oncology|January 25, 2018
HLA class I antigen processing machinery (APM) component expression and PD-1:PD-L1 pathway activation in HIV-infected head and neck cancersSara I Pai, J Jack Lee, Thomas E Carey, et al.
Journal of Biomedical Optics|January 5, 2011
Comparison of multispectral wide-field optical imaging modalities to maximize image contrast for objective discrimination of oral neoplasiaDarren Roblyer, Cristina Kurachi, Vanda Stepanek, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2017
Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial ImprovementChad Tang, Steven I Sherman, Mellanie Price, et al.
Pageof 60